Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 817

1.

Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder.

Guevara J, Lozano P, Wickizer T, Mell L, Gephart H.

Pediatrics. 2002 May;109(5):733-9.

PMID:
11986429
[PubMed - indexed for MEDLINE]
2.

Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.

Guevara J, Lozano P, Wickizer T, Mell L, Gephart H.

Pediatrics. 2001 Jul;108(1):71-8.

PMID:
11433056
[PubMed - indexed for MEDLINE]
3.

Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.

Radigan M, Lannon P, Roohan P, Gesten F.

J Child Adolesc Psychopharmacol. 2005 Feb;15(1):44-56.

PMID:
15741785
[PubMed - indexed for MEDLINE]
4.

Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.

Chen CY, Gerhard T, Winterstein AG.

J Child Adolesc Psychopharmacol. 2009 Apr;19(2):187-95. doi: 10.1089/cap.2008.096.

PMID:
19364296
[PubMed - indexed for MEDLINE]
5.

Continuity in methylphenidate treatment of adults with attention-deficit/hyperactivity disorder.

Olfson M, Marcus SC, Zhang HF, Wan GJ.

J Manag Care Pharm. 2007 Sep;13(7):570-7.

PMID:
17874863
[PubMed - indexed for MEDLINE]
Free Article
6.

Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care.

Boles M, Lynch FL, DeBar LL.

J Child Adolesc Psychopharmacol. 2001 Spring;11(1):43-52.

PMID:
11322744
[PubMed - indexed for MEDLINE]
7.

Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.

Rappley MD, Mullan PB, Alvarez FJ, Eneli IU, Wang J, Gardiner JC.

Arch Pediatr Adolesc Med. 1999 Oct;153(10):1039-45.

PMID:
10520611
[PubMed - indexed for MEDLINE]
8.

Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.

Goldman LS, Genel M, Bezman RJ, Slanetz PJ.

JAMA. 1998 Apr 8;279(14):1100-7. Review.

PMID:
9546570
[PubMed - indexed for MEDLINE]
9.

Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.

Klassen AF, Miller A, Fine S.

Pediatrics. 2004 Nov;114(5):e541-7.

PMID:
15520087
[PubMed - indexed for MEDLINE]
10.

Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.

Zito JM, Safer DJ, dosReis S, Magder LS, Gardner JF, Zarin DA.

Arch Pediatr Adolesc Med. 1999 Dec;153(12):1257-63.

PMID:
10591302
[PubMed - indexed for MEDLINE]
11.

Physician perceptions of the use of medications for attention deficit hyperactivity disorder.

Stockl KM, Hughes TE, Jarrar MA, Secnik K, Perwien AR.

J Manag Care Pharm. 2003 Sep-Oct;9(5):416-23.

PMID:
14613439
[PubMed - indexed for MEDLINE]
Free Article
12.

Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.

Sikirica V, Pliszka SR, Betts KA, Hodgkins P, Samuelson T, Xie J, Erder H, Dammerman R, Robertson B, Wu EQ.

J Manag Care Pharm. 2012 Nov-Dec;18(9):676-89.

PMID:
23206211
[PubMed - indexed for MEDLINE]
Free Article
13.

Use of medication by young people with attention-deficit/hyperactivity disorder.

Sawyer MG, Rey JM, Graetz BW, Clark JJ, Baghurst PA.

Med J Aust. 2002 Jul 1;177(1):21-5.

PMID:
12088474
[PubMed - indexed for MEDLINE]
14.

Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.

Jensen PS, Kettle L, Roper MT, Sloan MT, Dulcan MK, Hoven C, Bird HR, Bauermeister JJ, Payne JD.

J Am Acad Child Adolesc Psychiatry. 1999 Jul;38(7):797-804.

PMID:
10405496
[PubMed - indexed for MEDLINE]
15.

Pharmacological treatment patterns among patients with attention-deficit/hyperactivity disorder: retrospective claims-based analysis of a managed care population.

Christensen L, Sasané R, Hodgkins P, Harley C, Tetali S.

Curr Med Res Opin. 2010 Apr;26(4):977-89. doi: 10.1185/03007991003673617.

PMID:
20178404
[PubMed - indexed for MEDLINE]
16.

A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.

Faraone SV, Glatt SJ.

J Clin Psychiatry. 2010 Jun;71(6):754-63. doi: 10.4088/JCP.08m04902pur. Epub 2009 Dec 29.

PMID:
20051220
[PubMed - indexed for MEDLINE]
17.

Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder.

Perwien A, Hall J, Swensen A, Swindle R.

J Manag Care Pharm. 2004 Mar-Apr;10(2):122-9.

PMID:
15032561
[PubMed - indexed for MEDLINE]
Free Article
18.

Efficacy and safety limitations of attention-deficit hyperactivity disorder pharmacotherapy in children and adults.

Wigal SB.

CNS Drugs. 2009;23 Suppl 1:21-31. doi: 10.2165/00023210-200923000-00004. Review.

PMID:
19621975
[PubMed - indexed for MEDLINE]
19.

Patterns of psychotropic medication use in very young children with attention-deficit hyperactivity disorder.

Rappley MD, Eneli IU, Mullan PB, Alvarez FJ, Wang J, Luo Z, Gardiner JC.

J Dev Behav Pediatr. 2002 Feb;23(1):23-30.

PMID:
11889348
[PubMed - indexed for MEDLINE]
20.

National trends in the treatment of attention deficit hyperactivity disorder.

Olfson M, Gameroff MJ, Marcus SC, Jensen PS.

Am J Psychiatry. 2003 Jun;160(6):1071-7.

PMID:
12777264
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk